Metabolic Labeling of Pseudaminic Acid-Containing Glycans on Bacterial Surfaces

ACS Chemical Biology
Gloria AndolinaXuechen Li

Abstract

The rise in antibiotic-resistant bacteria is causing worldwide concerns. The urgent need for new antibacterial drugs calls for new thinking and strategies to explore novel, narrow-spectrum, and pathogen-specific antibacterial targets. Legionaminic acid (Leg) and pseudaminic acid (Pse) are nonulosonic acid carbohydrates with structural similarity to eukaryotic sialic acid, and are distributed in numerous pathogenic Gram-negative bacteria as components of cell surface-associated glycans. They are involved in the host interaction, pathogenicity, antiphage defense mechanism, and immune escape mechanism. To further explore their biological significance, we developed a synthesis of 2-acetamido-4-azidoacetamido-2,4,6-trideoxy-l-altrose (Alt-4NAz) and 2-azidoacetamido-4-acetamido-2,4,6-trideoxy-l-altrose (Alt-2NAz), among which Alt-4NAz served as an effective chemical reporter to realize bacterial Pse metabolic labeling. The effectiveness of this chemical reporter has been demonstrated in Pseudomonas aeruginosa, Vibrio vulnificus, and Acinetobacter baumannii strains. Expectedly, this strategy can provide a useful assay to detect phenotypic presence of Pse biosynthesis and screen for agents targeting this pathway.

References

Jun 21, 1996·Carbohydrate Research·P EdebrinkJ Hoffman
Feb 3, 1998·Journal of Immunological Methods·J I KeenanP F Bagshaw
Mar 17, 2000·Science·E Saxon, C R Bertozzi
May 9, 2001·The Journal of Biological Chemistry·P CastricR W Carlson
Jun 26, 2001·Glycoconjugate Journal·R Schauer
Jul 20, 2001·The Journal of Biological Chemistry·P ThibaultP Guerry
Jul 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·David J VocadloCarolyn R Bertozzi
Mar 10, 2004·Microbiology and Molecular Biology Reviews : MMBR·Eric R VimrSusan M Steenbergen
Nov 22, 2005·Infection and Immunity·James G SmedleyPeter Castric
Aug 2, 2008·The FEBS Journal·Susan M TwineSusan M Logan
Feb 3, 2009·Carbohydrate Research·Evguenii VinogradovDean A Rowe-Magnus
May 8, 2009·Chembiochem : a European Journal of Chemical Biology·Feng LiuMartin E Tanner
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Amanda L LewisAjit Varki
Aug 24, 2010·Chemical Communications : Chem Comm·Danielle H DubeBo Wang
Jun 21, 2011·Frontiers in Microbiology·Joseph S LamDana Kocíncová
May 2, 2012·Virulence·Aoife HowardRoy D Sleator
Feb 14, 2015·PLoS Pathogens·Edward Geisinger, Ralph R Isberg
Mar 1, 2015·FEMS Microbiology Reviews·M Sloan SiegristCarolyn R Bertozzi
Mar 24, 2016·Journal of the American Chemical Society·Someswara Rao Sanapala, Suvarn S Kulkarni
Jun 18, 2017·Frontiers in Microbiology·Sing-Peng HengLearn-Han Lee
Aug 25, 2017·Journal of the American Chemical Society·Han LiuXuechen Li
Nov 15, 2017·Nature Microbiology·Hanjeong HarveyLori L Burrows

❮ Previous
Next ❯

Citations

Jan 17, 2020·Chembiochem : a European Journal of Chemical Biology·Emily K P FlackMartin A Fascione
Nov 16, 2019·Chembiochem : a European Journal of Chemical Biology·Zhenrun J ZhangHoward C Hang
Oct 13, 2020·Frontiers in Cellular and Infection Microbiology·Wangxue Chen
Jun 16, 2021·Bioorganic & Medicinal Chemistry·Phuong Luong, Danielle H Dube
Jan 8, 2020·Chemical Science·Daniel A WilliamsDanielle H Dube
May 14, 2019·Journal of the American Chemical Society·Phillip J CalabrettaLaura L Kiessling
Oct 5, 2021·Journal of the American Chemical Society·Victoria M MarandoLaura L Kiessling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Bacterial Protein Structures (ASM)

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Related Papers

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Matthew E FalagasArgyris Michalopoulos
The American Journal of Nursing
Barrie GewanterStephanie Jones
© 2022 Meta ULC. All rights reserved